The experience of social support in patients suffering from treatment-refractory depression -: A pilot study

被引:6
|
作者
Skärsäter, I
Dencker, K
Ågren, H
机构
[1] Cent Hosp Halmstad, Dept Psychiat, SE-30185 Halmstad, Sweden
[2] Sahlgrens Univ Hosp, Dept Psychiat & Neurochem, Inst Clin Neursoci, Molndal, Sweden
[3] Univ Gothenburg, Coll Hlth Sci, Dept Nursing, Gothenburg, Sweden
[4] Huddinge Univ Hosp, Karolinska Inst, Div Psychiat, S-14186 Huddinge, Sweden
关键词
D O I
10.1016/S0883-9417(99)80025-9
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
The purpose of this study was (1) to ascertain to what extent a group of patients with treatment-refractory depression perceive that they have received sufficient social support, and (2) to define clinical variables that differentiate such patients from those who perceive that they have not received sufficient social support. Twenty-seven treatment-refractory patients with major depression were included in the study, The result showed that only 37% had what was judged as insufficient social support. Those with insufficient and sufficient social support had equally severe depressions, the same number of stressful life events, and the same number of persons in their social network. Patients with insufficient social support were characterized by (1) a subjective conviction that the number of persons in their network was insufficient, and (2) female gender. Emotional support was valued higher than any other kind of support. Copyright (C) 1999 by W.B. Saunders Company.
引用
收藏
页码:89 / 96
页数:8
相关论文
共 50 条
  • [41] Neurometabolic Disorders: Potentially Treatable Abnormalities in Patients With Treatment-Refractory Depression and Suicidal Behavior
    Pan, Lisa A.
    Martin, Petra
    Zimmer, Thomas
    Segreti, Anna Maria
    Kassiff, Sivan
    McKain, Brian W.
    Baca, Cynthia A.
    Rengasamy, Manivel
    Hyland, Keith
    Walano, Nicolette
    Steinfeld, Robert
    Hughes, Marion
    Dobrowolski, Steven K.
    Pasquino, Michele
    Diler, Rasim
    Perel, James
    Finegold, David N.
    Peters, David G.
    Naviaux, Robert K.
    Brent, David A.
    Vockley, Jerry
    AMERICAN JOURNAL OF PSYCHIATRY, 2017, 174 (01): : 42 - 50
  • [42] Population Pharmacokinetics and Pharmacodynamics of the Therapeutic and Adverse Effects of Ketamine in Patients with Treatment-Refractory Depression
    Abuhelwa, Ahmad Y.
    Somogyi, Andrew A.
    Loo, Colleen K.
    Glue, Paul
    Barratt, Daniel T.
    Foster, David J. R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 112 (03) : 720 - 729
  • [43] Rare variants and biological pathways identified in treatment-refractory depression
    McClain, Lora Lee
    Shaw, Patricia
    Sabol, Roisin
    Chedia, Anna Maria
    Segretti, Anna Maria
    Rengasamy, Manivel
    Finegold, David N.
    Pan, Lisa
    Peters, David Gerard
    JOURNAL OF NEUROSCIENCE RESEARCH, 2020, 98 (07) : 1322 - 1334
  • [44] Venlafaxine augmentation with methylphenidate for treatment-refractory depression: A case report
    Bader, GM
    Hawley, JM
    Short, DD
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1998, 18 (03) : 255 - 256
  • [46] Ketamine: A Potential Option For Treatment-Refractory Depression In Elder Adults
    Horr, T. B.
    Dale, R.
    Finnegan, N.
    Frankel, M.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2014, 62 : S179 - S179
  • [47] Reproducibility and durtion of the antidepressant effect of rRMS in treatment-refractory depression
    Thall, MR
    Mechanic, DJ
    Romero, JR
    Gangitano, M
    Pascual-Leone, A
    BIOLOGICAL PSYCHIATRY, 2001, 49 (08) : 47S - 47S
  • [48] Augmentation strategies for treatment-refractory clozapine patients
    Freudenreich, O.
    EUROPEAN PSYCHIATRY, 2021, 64 : S31 - S31
  • [49] High-dose armodafinil in treatment-refractory bipolar depression
    Kwok, Wan Y.
    Stephens, Victoria
    Nasrallah, Henry A.
    ANNALS OF CLINICAL PSYCHIATRY, 2023, 35 (03) : 195 - 198
  • [50] Predictors of Clozapine Response in Patients With Treatment-Refractory Schizophrenia Results From a Danish Register Study
    Nielsen, Jimmi
    Nielsen, Rene Ernst
    Correll, Christoph U.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2012, 32 (05) : 678 - 683